You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 72 No. 4, October 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Ouabain on Active Transport of Sodium in the Cornea

BRENT LAMBERT, BS; ANTHONY DONN, MD

Arch Ophthalmol. 1964;72(4):525-528.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Ouabain (G-Strophanthin) inhibits the activity of Na-K activated adenosinetriphosphatase (ATPase) in in vitro and in vivo systems.1-3 The active transport of Na and K across the membranes of frog skin and erythrocytes is also inhibited by ouabain.4,5 Simon and Bonting6 have shown Na-K activated ATPase to be present in the ciliary body and to be inhibited by ouabain. Administration of ouabain resulted in a decrease in aqueous flow and a drop in intraocular pressure, presumably due to an inhibition of sodium transport across the ciliary epithelium.6A The corneal epithelium actively transports sodium,7 but the enzyme Na-K activated ATPase has not yet been demonstrated in this tissue. It was the purpose of this investigation to study the effect of ouabain on the active transport of sodium across the corneal epithelium.

Method

A technique for maintaining rabbit corneas alive between two Lucite chambers so that the . . . [Full Text PDF of this Article]


Author Affiliations

New York

Summer fellow on a Fight for Sight Fellowship (Mr. Lambert).; From the Department of Ophthalmology, Institute of Ophthalmology, Columbia-Presbyterian Medical Center, Columbia University.


Footnotes

Read before the Eastern Section Meeting of the Association for Research in Ophthalmology, March 8, 1963.

This work was supported by National Institutes of Health Grant No. NB 02343-05.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.